Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Teachers Retirement System of The State of Kentucky

Teachers Retirement System of The State of Kentucky lowered its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 4.7% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 375,564 shares of the company’s stock after selling 18,690 shares during the quarter. Teachers Retirement System of The State of Kentucky owned approximately 0.22% of Option Care Health worth $12,597,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in OPCH. Raymond James & Associates boosted its position in Option Care Health by 200.9% during the 4th quarter. Raymond James & Associates now owns 50,047 shares of the company’s stock valued at $1,686,000 after purchasing an additional 33,414 shares during the period. Pacer Advisors Inc. boosted its position in Option Care Health by 76.8% during the 4th quarter. Pacer Advisors Inc. now owns 26,618 shares of the company’s stock valued at $897,000 after purchasing an additional 11,565 shares during the period. Trust Point Inc. acquired a new position in Option Care Health during the 4th quarter valued at approximately $525,000. Riverbridge Partners LLC boosted its position in Option Care Health by 49.5% during the 4th quarter. Riverbridge Partners LLC now owns 1,792,012 shares of the company’s stock valued at $60,373,000 after purchasing an additional 593,706 shares during the period. Finally, International Assets Investment Management LLC boosted its position in Option Care Health by 1,513.7% during the 4th quarter. International Assets Investment Management LLC now owns 3,066 shares of the company’s stock valued at $103,000 after purchasing an additional 2,876 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Stock Performance

Option Care Health stock traded up $0.84 during mid-day trading on Friday, hitting $31.61. 2,323,590 shares of the company’s stock traded hands, compared to its average volume of 1,971,982. Option Care Health, Inc. has a one year low of $26.11 and a one year high of $35.74. The company has a quick ratio of 1.39, a current ratio of 1.76 and a debt-to-equity ratio of 0.78. The firm has a 50 day moving average price of $29.10 and a 200 day moving average price of $30.69. The company has a market cap of $5.41 billion, a PE ratio of 20.80, a price-to-earnings-growth ratio of 2.33 and a beta of 1.24.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Wednesday, July 31st. The company reported $0.30 EPS for the quarter, topping analysts’ consensus estimates of $0.27 by $0.03. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The company had revenue of $1.23 billion for the quarter, compared to the consensus estimate of $1.17 billion. During the same quarter in the previous year, the business earned $0.63 EPS. The company’s quarterly revenue was up 14.8% compared to the same quarter last year. On average, equities analysts forecast that Option Care Health, Inc. will post 1.21 EPS for the current year.

Analysts Set New Price Targets

Several brokerages have weighed in on OPCH. JMP Securities began coverage on Option Care Health in a research note on Tuesday, July 16th. They set an “outperform” rating and a $36.00 target price on the stock. Barrington Research lifted their target price on Option Care Health from $38.00 to $40.00 and gave the company an “outperform” rating in a research note on Thursday.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.